http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112022004645-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9a180ec762882012ba9264eaea62953
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-438
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2020-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3112bee376885230ba809df988a31154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_151c5d5326a3a0aec0e5a407c0638b66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23164eb83ed457a8cfb626f3f2428626
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97963d441f2c32f00cf9a09d0b8d0911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2cb11c1b53c19643d96a6db911a64c9
publicationDate 2022-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112022004645-A2
titleOfInvention Combination therapies with antibiotics
abstract combination therapies with antibiotics. the invention provides antibiotic combination therapies for the treatment of an a. baumannii in an individual. combination therapies include rifabutin and a second antibiotic, such as colistin and cefiderocol.
priorityDate 2019-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139033164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428598458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID202195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419564755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457619940

Total number of triples: 35.